Sagimet Biosciences

(NASDAQ) SGMT

Current Price$7.75

Market Cap$476.11M

Since IPO (2023)-52%

5 YearN/A

1 Year+141%

1 Month+38%

Sagimet Biosciences Financials at a Glance

Market Cap

$476.11M

Revenue (TTM)

$0.00

Net Income (TTM)

$51.04M

EPS (TTM)

$-1.58

P/E Ratio

-4.88

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$7.75

Volume

675,705.174

Open

$7.70

Price

$7.75

Volume

675,705.174

Open

$7.70

Previous Close

$7.71

Daily Range

$7.58 - $7.91

52-Week Range

$3.08 - $11.41

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$7.75

Volume

675,705.174

Open

$7.70

Previous Close

$7.71

Daily Range

$7.58 - $7.91

52-Week Range

$3.08 - $11.41

SGMT News

Why Sagimet Biosciences Stock Is Soaring Today

James BrumleyApr 27, 2026

Sagimet Biosciences Tops Q2 EPS Forecast

Motley Fool Markets TeamAug 13, 2025

SGMT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sagimet Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David A. Happel, MBA

Website

www.sagimet.com

Headquarters

San Mateo, CA 94402, US

SGMT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-38%

Return on Capital

-51%

Return on Assets

-44%

Earnings Yield

-20.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$476.11M

Shares Outstanding

61.75M

Volume

675.71K

Avg. Volume

1.36M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$56.89M

EBITDA

$56.89M

Operating Cash Flow

$45.65M

Capital Expenditure

$0.00

Free Cash Flow

$45.65M

Cash & ST Invst.

$113.12M

Total Debt

$78.00K

Sagimet Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$476.11M

N/A

Market Cap/Employee

$34.01M

N/A

Employees

N/A

Net Income

$9.57M

+40.9%

EBITDA

$12.19M

+24.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$113.05M

-25.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$78.00K

+0.0%

Return on Assets

-43.82%

N/A

Return on Invested Capital

-51.08%

N/A

Free Cash Flow

$11.83M

-7.3%

Operating Cash Flow

$11.83M

-7.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ASMBAssembly Biosciences, Inc.

ASMBAssembly Biosciences, Inc.$30.13+1.31%

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$5.38-0.88%

ZURAZura Bio Limited

ZURAZura Bio Limited$4.69-2.09%

ACHVAchieve Life Sciences, Inc.

ACHVAchieve Life Sciences, Inc.$5.49+5.28%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$7.00+2.41%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.35-2.03%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$4.12+1.60%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

POETPoet Technologies

POETPoet Technologies$13.96+0.28%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.78+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.31-0.01%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$6.79-0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.93+0.08%

NOKNokia

NOKNokia$13.87+0.08%

NVDANvidia

NVDANvidia$219.23+0.02%

Questions About SGMT

What is the current price of Sagimet Biosciences?

Sagimet Biosciences is trading at $7.78 per share.

What is the 52-week range for Sagimet Biosciences?

Over the past 52 weeks, Sagimet Biosciences has traded between $3.08 and $11.41.

How much debt does Sagimet Biosciences have?

As of the most recent reporting period, Sagimet Biosciences reported total debt of $78,000.

How much cash does Sagimet Biosciences have on hand?

Sagimet Biosciences reported $35.02M in cash and cash equivalents in its most recent financial results.

What is Sagimet Biosciences’s dividend yield?

Sagimet Biosciences does not currently have a dividend yield.

Sagimet Biosciences

Sagimet Biosciences Financials at a Glance

SGMT News

Why Sagimet Biosciences Stock Is Soaring Today

Sagimet Biosciences Tops Q2 EPS Forecast

SGMT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Sagimet Biosciences

SGMT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Sagimet Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SGMT

What is the current price of Sagimet Biosciences?

What is the 52-week range for Sagimet Biosciences?

How much debt does Sagimet Biosciences have?

How much cash does Sagimet Biosciences have on hand?

What is Sagimet Biosciences’s dividend yield?

Premium Investing Services